$0.02
(Market cap
$14 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-21 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1.1
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
7,098,740
10 Years Aggregate
CFO
$-168.15 Mln
EBITDA
$-193.36 Mln
Net Profit
$-196.22 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Celsion (CLSN)
| -82.1 | -4.6 | -36.4 | -87.1 | -58.2 | -49.2 | -56.6 |
|
BSE Sensex*
| -9.5 | 1.6 | 2.8 | -7.0 | 6.6 | 7.8 | 11.1 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Celsion (CLSN)
| -24.1 | -58.4 | 21.3 | -47.2 | -37.0 | -84.2 | -17.6 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Celsion (CLSN)
|
1.5 | 13.9 | 0.5 | -26.9 | -3,186.4 | -61.4 | -- | 0.2 |
| 286.4 | 37,128.5 | 4,286.9 | 577.2 | 20.3 | 88.2 | 69.9 | 34.5 | |
| 82.0 | 11,524.9 | 622.0 | -300.9 | -25.7 | -61.1 | -- | 18.7 | |
| 51.4 | 13,047.8 | 2,375.5 | 833.4 | 41.5 | 40.7 | 17.2 | 6.7 | |
| 167.8 | 28,000.8 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 20.9 | 4.5 | |
| 512.9 | 11,660.4 | 1,132.5 | -309.4 | -25.0 | -52.9 | -- | 21.4 | |
| 455.7 | 13,143.2 | 2,678.3 | 460.4 | 21.3 | 103.2 | 29 | 22.0 | |
| 612.5 | 63,945.5 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 14.9 | 2.0 | |
| 538.3 | 22,776.5 | 3,169.8 | 1,287.4 | 51.3 | 20.6 | 19.8 | 3.9 | |
| 466.8 | 114,626.1 | 12,255.1 | 4,338.3 | 42.2 | 23.7 | 26.8 | 5.9 |
Shareholding Pattern
View DetailsAbout Celsion (CLSN)
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the... localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey. Read more
-
Exec. Chairman
Mr. Michael H. Tardugno
-
Exec. Chairman
Mr. Michael H. Tardugno
-
Headquarters
Lawrenceville, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Celsion (CLSN)
What is the current share price of Celsion Corporation (CLSN) Today?
The share price of Celsion Corporation (CLSN) is $1.45 (NASDAQ) as of 22-Nov-2022 09:30 EDT. Celsion Corporation (CLSN) has given a return of -58.16% in the last 3 years.
What is the current PB & PE ratio of Celsion Corporation (CLSN)?
Since, TTM earnings of Celsion Corporation (CLSN) is negative, P/E ratio is not available.
The P/B ratio of Celsion Corporation (CLSN) is 0.24 times as on 22-Nov-2022, a 94 discount to its peers’ median range of 4.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
What is the 52 Week High and Low of Celsion Corporation (CLSN)?
The 52-week high and low of Celsion Corporation (CLSN) are Rs -- and Rs -- as of 23-Jun-2026.
What is the market cap of Celsion Corporation (CLSN)?
Celsion Corporation (CLSN) has a market capitalisation of $ 14 Mln as on 22-Nov-2022. As per SEBI classification, it is a company.
Should I invest in Celsion Corporation (CLSN)?
Before investing in Celsion Corporation (CLSN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.